Literature DB >> 22158067

Switching from high-fat to low-fat diet normalizes glucose metabolism and improves glucose-stimulated insulin secretion and insulin sensitivity but not body weight in C57BL/6J mice.

Carl-David Agardh1, Bo Ahrén.   

Abstract

OBJECTIVES: Environmental factors such as a high-fat diet contribute to type 2 diabetes and obesity. This study examined glycemia, insulin sensitivity, and β-cell function after switching from a high-fat diet to a low-fat diet in mice.
METHODS: C57BL/6J mice were fed a high-fat diet or low-fat diet for 18 months, after which mice on the high-fat diet either maintained this diet or switched to a low-fat diet for 4 weeks. Body weight and glucose and insulin responses to intraperitoneal glucose were determined. Insulin secretion (insulinogenic index: the 10-minute insulin response divided by the 10-minute glucose level) and insulin sensitivity (1 divided by basal insulin) were determined.
RESULTS: After 18 months on a high-fat diet, mice had glucose intolerance, marked hyperinsulinemia, and increased body weight compared to mice on a low-fat diet (P < 0.001). Switching from a high-fat diet to low-fat diet normalized glucose tolerance, reduced but not normalized body weight (P < 0.001), increased insulin secretion (248 ± 39 vs 141 ± 46 pmol/mmol; P = 0.028) and improved but not normalized insulin sensitivity (3.2 ± 0.1 vs 1.0 ± 0.1 [pmol/L]; P = 0.012).
CONCLUSION: Switching from a high-fat diet to low-fat diet normalizes glucose tolerance and improves but not normalizes insulin secretion and insulin sensitivity. These effects are more pronounced than the reduced body weight.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22158067     DOI: 10.1097/MPA.0b013e3182243107

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  6 in total

1.  Genetic variation of habitual coffee consumption and glycemic changes in response to weight-loss diet intervention: the Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) trial.

Authors:  Liyuan Han; Wenjie Ma; Dianjianyi Sun; Yoriko Heianza; Tiange Wang; Yan Zheng; Tao Huang; Donghui Duan; J George A Bray; Catherine M Champagne; Frank M Sacks; Lu Qi
Journal:  Am J Clin Nutr       Date:  2017-09-20       Impact factor: 7.045

2.  Reversing diet-induced metabolic dysregulation by diet switching leads to altered hepatic de novo lipogenesis and glycerolipid synthesis.

Authors:  Greg M Kowalski; Steven Hamley; Ahrathy Selathurai; Joachim Kloehn; David P De Souza; Sean O'Callaghan; Brunda Nijagal; Dedreia L Tull; Malcolm J McConville; Clinton R Bruce
Journal:  Sci Rep       Date:  2016-06-07       Impact factor: 4.379

3.  The Metabolic Syndrome: Emerging Novel Insights Regarding the Relationship between the Homeostasis Model Assessment of Insulin Resistance and other Key Predictive Markers in Young Adults of Western Algeria.

Authors:  Mohammed Ilyes Belhayara; Zoheir Mellouk; Mohammed Seddik Hamdaoui; Malika Bachaoui; Omar Kheroua; Willy J Malaisse
Journal:  Nutrients       Date:  2020-03-10       Impact factor: 5.717

4.  Exposure to maternal high-fat diet induces extensive changes in the brain of adult offspring.

Authors:  Darren J Fernandes; Shoshana Spring; Jason P Lerch; Mark R Palmert; Anna R Roy; Lily R Qiu; Yohan Yee; Brian J Nieman
Journal:  Transl Psychiatry       Date:  2021-03-02       Impact factor: 6.222

5.  Moderate calorie restriction to achieve normal weight reverses β-cell dysfunction in diet-induced obese mice: involvement of autophagy.

Authors:  Xiuying Gao; Dien Yan; Yinan Zhao; Hong Tao; Yingsheng Zhou
Journal:  Nutr Metab (Lond)       Date:  2015-10-06       Impact factor: 4.169

6.  Dietary challenges differentially affect activity and sleep/wake behavior in mus musculus: Isolating independent associations with diet/energy balance and body weight.

Authors:  Isaac J Perron; Brendan T Keenan; Karthikeyani Chellappa; Nicholas F Lahens; Nicole L Yohn; Keith R Shockley; Allan I Pack; Sigrid C Veasey
Journal:  PLoS One       Date:  2018-05-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.